[Federal Register Volume 62, Number 220 (Friday, November 14, 1997)]
[Notices]
[Page 61148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29973]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 29, 1997, and published in the Federal 
Register on August 26, 1997, (62 FR 45272), Novartis Pharmaceuticals 
Corp., 59 Route 10, East Hanover, New Jersey 07936, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of methylphenidate (1724) a basic class of 
controlled substance listed in Schedule II.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Novartis 
Pharmaceuticals Corp. to manufacture methylphenidate is consistent with 
the public interest at this time. Therefore, pursuant to 21 U.S.C. 
Sec. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed above is 
granted.

    Dated: November 6, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-29973 Filed 11-13-97; 8:45 am]
BILLING CODE 4410-09-M